期刊名称:NANOMEDICINE
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.
As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.
Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field ?academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.
Coverage includes:
Principles of nanomedicine, including basic research and theoretical applications
Nanotechnological advances and their potential medical applications
Disorders/conditions and the benefits of nanomedical tools versus traditional techniques
Pre-clinical testing of novel nanomedical tools
Diagnostic tools and applications
Implanted nanodevices for the prevention and treatment of disease and the alleviation of pain
Nanomedical tools in gene therapy for inherited diseases
Tissue, cell and genetic engineering involving nanomedical tools
Therapeutic applications of nanotechnology
Drug delivery using nano-particles (natural and artificial) or -devices
Technologies already in clinical use: diagnostics, therapeutics or surgical aids
Prediction of adverse reactions of nanomedical technology, toxicology and safety issues
Ethical, regulatory and legal issues
Commercialization, funding and economics of nanomedical technology
The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.
Instructions to Authors
We accept unsolicited manuscripts for publication in Future Medicine journals. All review articles published in the journals are subject to rigorous peer-review by independent experts in the field. If you are interested in submitting an article, please contact the Commissioning Editor of the relevant journal with a brief proposal and article outline in the first instance. We also have an active commissioning program whereby the Commissioning Editor, under the advice of the Editorial Advisory Board, solicits articles for publication by Future Medicine.
The following guidelines (PDF files) are provided to assist authors in the preparation of their manuscript.
Future series
Future Cardiology
Future HIV Therapy
Future Lipidology
Future Microbiology
Future Neurology
Future Oncology
Future Rheumatology
Future Virology
Health series
Aging Health
Women's Health
Biomarkers in Medicine
General Guidelines (reviews, perspectives, technology reports, special reports)
Conference Report
Editorial
Nanomedicine
General Guidelines (reviews, perspectives, technology reports, special reports)
Company Profile
Conference Report
Personalized Medicine
General Guidelines (reviews, perspectives, technology reports, special reports)
Research Report (original papers)
Company Profile
Conference Report
Editorial
Pharmacogenomics
General Guidelines (reviews, perspectives, technology reports, special reports)
Research Report (original papers)
Company Profile
Conference Report
Editorial
Regenerative Medicine
General Guidelines (review, perspectives, technology reports, special reports)
Company Profile Guidelines
Conference Report Guidelines
Therapy
General Guidelines
References
The Future Medicine EndNote style for references is available here (compatible with Mac EndNote 9).
Submission
Please submit manuscripts in Microsoft Word 2000 format via e-mail to the Commissioning Editor of the relevant journal. Figures should be submitted as Microsoft PowerPoint, Adobe Illustrator or Photoshop (*.eps). Graphs and charts can also be submitted as Microsoft Excel.
Copyright
As the author of your manuscript, you are responsible for obtaining permissions to use material owned by others. Since the permission-seeking process can be time-consuming, it is wise to request permission as soon as possible. A template permission letter is available upon request by contacting the Commissioning Editor of the relevant journal. Please send us photocopies of letters or forms granting you permission for the use of copyrighted material so that we can see that any special requirements with regard to wording and placement of credits are fulfilled. Please keep the originals for your files.
Editorial Board
Srivastava D, NASA Ames, USA
Stockley PG, University of Leeds, UK
Storm G, University of Utrecht, NL
Stupp SI, Northwestern University, IL, USA
Suk WA, Natl Instit. Environ. Hlth Sci., NC, USA
Toms SA, Cleveland Clinic Foundn, OH, USA
Toner M, Mass. Gen. Hosp. & Harvard Med. Sch., USA
Vo-Dinh T, Oak Ridge Natnl Lab., TN, USA
Wheeler BC, University of Illinois, IL, USA
|